echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > "Vaccine Nationalism" highlights a "selfish America"

    "Vaccine Nationalism" highlights a "selfish America"

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The new crown epidemic is still spreading around the world, and many countries in the world have adopted vaccination as an effective way to prevent new crown virus infection .


    Prevent infection

    Self-vaccine surplus

    As one of the most severely affected countries in the world, the United States is "ambitious" in promoting new crown vaccination.


    Since last year, the United States has not hesitated to spend a lot of money to sign large orders, from Pfizer Pharmaceuticals, Modena and other companies to grab orders for a variety of vaccines that are still in clinical trials.


    Since Johnson & Johnson’s vaccine is a single-dose form, it can be estimated that the number of vaccines currently ordered in the United States is sufficient to vaccinate 450 million people, while the US population is about 331 million.


    Japan’s "Mainichi Shimbun" pointed out that the Biden administration emphasized that foreign aid will only be officially launched when a certain degree of herd immunity is achieved in the United States .


    immunity

    Export but control

    Although a large number of vaccines are being left unused, the United States has imposed strict controls on the export of vaccines, and even moved out of the "National Defense Production Law," which was used only during wartime, to impose export controls on raw materials for vaccine production.


    Mahima Datra, CEO of India Biotech E, said that American suppliers cannot execute orders from global customers due to the National Defense Production Act.


    As the main manufacturer of the new crown vaccine developed by Novavax in the United States, Adal Punawara, CEO of the Serum Institute of India, also said that the inability to obtain raw materials from the United States will seriously hinder vaccine production.


    World Health Organization Director-General Tan Desai recently warned that the shortage of key materials for global new crown vaccine production has not only restricted the production of new crown vaccines, but also restricted the production of conventional childhood immunization vaccines.


    child

    Delay in sharing vaccines

    Biden said a few days ago that the United States is in discussions with several countries to determine which country can obtain the surplus vaccines in the United States, but emphasized that before providing vaccines to other countries, it must first ensure that all Americans can get the vaccine.


    As close neighbors of the United States, Mexico and Canada once closed their doors when seeking to share the surplus of the new coronavirus vaccine in the United States.


    Some non-governmental organizations have also criticized the United States' new crown vaccine procurement strategy, calling on the White House to clearly set the upper limit of vaccine procurement and share the vaccine with other countries.


    Under the pressure of increasing criticism from the outside world, the United States finally announced on the 18th that it will provide 2.


    International public opinion pointed out that, as the world's number one power, the United States has been so forward-looking and slow to act when "lending" vaccines to neighboring countries.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.